-
公开(公告)号:US09278953B2
公开(公告)日:2016-03-08
申请号:US14506752
申请日:2014-10-06
Applicant: Pfizer Inc.
Inventor: Kevin Barry Bahnck , David James Edmonds , Kentaro Futatsugi , Esther Cheng Yin Lee , Alan Martin Mathiowetz , Elnaz Menhaji-Klotz , Robert Vernon Stanton
IPC: C07D213/63 , A61K31/44 , C07D401/14
CPC classification number: C07D401/14
Abstract: Provided herein are antagonists of prostaglandin EP3 receptor, processes to make said antagonists, and methods comprising administering said antagonists to a mammal in need thereof.
Abstract translation: 本文提供前列腺素EP3受体的拮抗剂,制备所述拮抗剂的方法,以及包括向有需要的哺乳动物施用所述拮抗剂的方法。
-
公开(公告)号:US20150099782A1
公开(公告)日:2015-04-09
申请号:US14506752
申请日:2014-10-06
Applicant: PFIZER INC.
Inventor: Kevin Barry Bahnck , David James Edmonds , Kentaro Futatsugi , Esther Cheng Yin Lee , Alan Martin Mathiowetz , Elnaz Menhaji-Klotz , Robert Vernon Stanton
IPC: C07D401/14
CPC classification number: C07D401/14
Abstract: Provided herein are antagonists of prostaglandin EP3 receptor, processes to make said antagonists, and methods comprising administering said antagonists to a mammal in need thereof.
Abstract translation: 本文提供前列腺素EP3受体的拮抗剂,制备所述拮抗剂的方法,以及包括向有需要的哺乳动物施用所述拮抗剂的方法。
-
公开(公告)号:US09738626B2
公开(公告)日:2017-08-22
申请号:US14970930
申请日:2015-12-16
Applicant: Pfizer Inc.
Inventor: Kevin Bahnck , Daniel Canterbury , David James Edmonds , Kentaro Futatsugi , Esther Cheng Yin Lee , Elnaz Menhaji-Klotz , Jana Polivkova , Robert Vernon Stanton
IPC: C07D401/14
CPC classification number: C07D401/14
Abstract: Provided herein are antagonists of prostaglandin EP3 receptor, processes to make said antagonists, and methods comprising administering said antagonists to a mammal in need thereof.
-
公开(公告)号:US20160176851A1
公开(公告)日:2016-06-23
申请号:US14970930
申请日:2015-12-16
Applicant: Pfizer Inc.
Inventor: Kevin Bahnck , Daniel Canterbury , David James Edmonds , Kentaro Futatsugi , Esther Cheng Yin Lee , Elnaz Menhaji-Klotz , Jana Polivkova , Robert Vernon Stanton
IPC: C07D401/14
CPC classification number: C07D401/14
Abstract: Provided herein are antagonists of prostaglandin EP3 receptor, processes to make said antagonists, and methods comprising administering said antagonists to a mammal in need thereof.
-
-
-